Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2018 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks about a specific phenomenon: the unit size of repeatable business escalating. We need to find if management conveys that deals, orders, contracts, projects, customers, sites, or programs are individually bigger, broader, or longer than before. Let's scan the transcript for any such statements. Management discusses various segments. In HPMC, John Sims talks about growth in aerospace and defense, next-generation engine products, etc. But does he mention that the size of individual orders or contracts is increasing? He mentions "emergent demand" and "additional volume" but not necessarily larger unit size. He says "we have seen emergent demand above the contractual share that we have won on certain parts" - that suggests more volume, not necessarily larger contracts. He also mentions "we are seeing that in 2018" but no comparison of size. In FRP, Bob Wetherbee discusses the A&T Stainless joint venture, STAL expansion, and potential conversion agreements. He mentions "large-scale trials" for multiple carbon steel producers, but does he say that the deals are getting bigger? He says "we continue to expect that we will sign at least one conversion agreement in 2018" - that's a hope, not a pattern of escalation. He also mentions the JV formation, but that's a one-time event. Rich Harshman in his remarks talks about "solid top-line growth" and "product mix enhancements" but nothing about increasing deal size. He mentions "emergent demand" and "opportunities" but not that each new engagement is larger. Pat DeCourcy talks about free cash flow and capital expenditures, but not about deal size. The question specifically asks: "does management convey that the deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago?" I don't see any such statement. There is no mention of average order size increasing, or that new customers are starting at larger scale, or that follow-on commitments are multiples. The only possible hint is in the context of the isothermal press investment, but that's about capacity expansion, not about the size of individual contracts.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.